Journal article
Long-Term Outcomes of SABR to Primary Renal Cell Carcinoma: A Multicenter Analysis from IROCK (International Radiosurgery Oncology Consortium for Kidney)
Abstract
Purpose/Objective(s) Patients with renal cell carcinoma (RCC) not suitable for surgery have few curative treatment options, particularly as thermal ablation has diminishing efficacy in RCC > 3 cm or adjacent to collecting system. Stereotactic ablative body radiotherapy (SABR) is a novel option limited by lack of long-term outcome data. We hypothesize that SABR represents an effective and safe, nephron-sparing alternative for RCC in the …
Authors
Siva S; Correa RJM; Ali M; Muacevic A; Ponsky L; Ellis RJ; Lo SS; Onishi H; Swaminath A; McLaughlin M
Journal
International Journal of Radiation Oncology • Biology • Physics, Vol. 114, No. 3,
Publisher
Elsevier
Publication Date
November 2022
DOI
10.1016/j.ijrobp.2022.07.476
ISSN
0360-3016